BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 21316753)

  • 1. Lowering blood pressure in acute stroke: the SCAST trial.
    Hankey GJ
    Lancet; 2011 Feb; 377(9767):696-8. PubMed ID: 21316753
    [No Abstract]   [Full Text] [Related]  

  • 2. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial.
    Sandset EC; Bath PM; Boysen G; Jatuzis D; Kõrv J; Lüders S; Murray GD; Richter PS; Roine RO; Terént A; Thijs V; Berge E;
    Lancet; 2011 Feb; 377(9767):741-50. PubMed ID: 21316752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering?
    Serebruany VL; Atar D; Hanley DF
    Cerebrovasc Dis; 2008; 26(5):563-4. PubMed ID: 18936537
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of high blood pressure in acute stroke--the SCAST study.
    Kjeldsen SE; Hedner T; Narkiewicz K; Oparil S
    Blood Press; 2011 Apr; 20(2):67-8. PubMed ID: 21405956
    [No Abstract]   [Full Text] [Related]  

  • 5. The X-cellent Study.
    Safar ME
    Am J Hypertens; 2006 Jan; 19(1):8-9. PubMed ID: 16461182
    [No Abstract]   [Full Text] [Related]  

  • 6. Renin-angiotensin system blockade safely reduces blood pressure in patients with minor ischemic stroke during the acute phase.
    Nakamura T; Tsutsumi Y; Shimizu Y; Uchiyama S
    J Stroke Cerebrovasc Dis; 2010; 19(6):435-40. PubMed ID: 20702114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure management in acute stroke: does the Scandinavian Candesartan Acute Stroke Trial (SCAST) resolve all of the unanswered questions?
    Fischer U; Rothwell PM
    Stroke; 2011 Oct; 42(10):2995-8. PubMed ID: 21852619
    [No Abstract]   [Full Text] [Related]  

  • 8. [AT-1 blockers are different in their effects. The forgetful patients begin to notice it especially].
    MMW Fortschr Med; 2003 Apr; 145(15):62. PubMed ID: 15104271
    [No Abstract]   [Full Text] [Related]  

  • 9. [In view of the findings of the SCAST study, must the treatment of arterial pressure in the acute phase of stroke be changed?].
    Castilla-Guerra L; Fernández-Moreno MC; Álvarez-Suero J; Jiménez Hernández MD
    Rev Neurol; 2011 Dec; 53(12):766-7. PubMed ID: 22127665
    [No Abstract]   [Full Text] [Related]  

  • 10. [Angiotensin II receptor blockers--evidence along the cardiovascular continuum].
    Zeller A; Battegay E
    Praxis (Bern 1994); 2005 Apr; 94(15):581-94. PubMed ID: 15884724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke: blood pressure lowering in acute stroke--scant joy from SCAST.
    Arima H; Chalmers J
    Nat Rev Cardiol; 2011 Apr; 8(7):366-8. PubMed ID: 21587216
    [No Abstract]   [Full Text] [Related]  

  • 12. ONTARGET, TRANSCEND and PROFESS--clarifying, confusing or misleading?
    Oparil S; Kjeldsen SE; Hedner T; Narkiewicz K
    Blood Press; 2009; 18(1-2):4-6. PubMed ID: 19191085
    [No Abstract]   [Full Text] [Related]  

  • 13. An overview of candesartan in clinical practice.
    Khawaja Z; Wilcox CS
    Expert Rev Cardiovasc Ther; 2011 Aug; 9(8):975-82. PubMed ID: 21878042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exforge HCT.
    Med Lett Drugs Ther; 2009 Jun; 51(1314):47. PubMed ID: 19528888
    [No Abstract]   [Full Text] [Related]  

  • 15. Relation between change in blood pressure in acute stroke and risk of early adverse events and poor outcome.
    Sandset EC; Murray GD; Bath PM; Kjeldsen SE; Berge E;
    Stroke; 2012 Aug; 43(8):2108-14. PubMed ID: 22627991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Importance of a fixed combination of AT1-receptor blockade and hydrochlorothiazide for blood pressure lowering in cardiac risk patients. A postmarketing surveillance study with candesartan/HCTZ].
    Bramlage P; Schönrock E; Odoj P; Wolf WP; Funken C
    MMW Fortschr Med; 2008 Feb; 150(6):40. PubMed ID: 18323344
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of high-normal blood pressure with angiotensin receptor blockers. TROPHY Study (Trial of Preventing Hypertension)].
    Mann J
    Internist (Berl); 2007 Apr; 48(4):436-8. PubMed ID: 17342351
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood pressure variability: the challenge of variation.
    Marshall TP
    Am J Hypertens; 2008 Jan; 21(1):3-4. PubMed ID: 18091733
    [No Abstract]   [Full Text] [Related]  

  • 19. New data on ONTARGET: more confusion?
    Escobar C; Echarri R; Barrios V
    J Clin Hypertens (Greenwich); 2010 Mar; 12(3):199. PubMed ID: 20433538
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study on cognition and prognosis in the elderly].
    Kohara K
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():425-30. PubMed ID: 16981574
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.